Literature DB >> 7867309

Evaluation of 80% inhibition standards for the determination of fluconazole minimum inhibitory concentrations in three laboratories.

A Espinel-Ingroff1, L Steele-Moore, J N Galgiani.   

Abstract

The purpose of this study was to evaluate 1:5 growth control dilutions (80% inhibition standards) to determine fluconazole minimum inhibitory concentration (MIC) end points in three laboratories. We tested 39 selected Candida species (in vitro susceptible: fluconazole MIC of < or = 1 microgram/ml, and resistant: fluconazole MIC of > or = 8 micrograms/ml) and Cryptococcus neoformans isolates by broth macro- and microdilution procedures following the National Committee for Clinical Laboratory Standards proposed reference method for yeasts (M27-P). Macrodilution MIC80% were the lowest drug concentrations with turbidity (growth) less than or equal to that of specific 1:5 dilutions of the growth control. Microdilution MICs-2 were the lowest drug concentrations in which there was prominent decrease of growth. A total of 1608 MICs were evaluated. C. krusei, C. parapsilosis, and C. tropicalis strains had reproducible fluconazole MICs by both tests (24 and 48 h). Fluconazole MIC80% and MIC-2 end points were consistent at 24 h (with C. albicans) and more variable at 48 h. MICs of C. neoformans were more reproducible at 72 h than at 48 h by both tests. This study suggests that the determination of fluconazole MICs is dependent on the length of incubation and the yeast being tested, and that antifungal testing of the yeasts may be performed by either test.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7867309     DOI: 10.1016/0732-8893(94)90096-5

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  14 in total

1.  Comparative study of agar diffusion test and the NCCLS macrobroth method for in vitro susceptibility testing of Candida spp.

Authors:  L M Soni; M N Burattini; A C Pignatari; O F Gompertz; A L Colombo
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

2.  In vitro susceptibilities of clinical yeast isolates to the new antifungal eberconazole compared with their susceptibilities to clotrimazole and ketoconazole.

Authors:  J M Torres-Rodríguez; R Mendez; O López-Jodra; Y Morera; M Espasa; T Jimenez; C Lagunas
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

3.  Susceptibilities of clinical and laboratory isolates of Blastomyces dermatitidis to ketoconazole, itraconazole, and fluconazole.

Authors:  S W Chapman; P D Rogers; M G Rinaldi; D C Sullivan
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

4.  Optimizing the correlation between results of testing in vitro and therapeutic outcome in vivo for fluconazole by testing critical isolates in a murine model of invasive candidiasis.

Authors:  J H Rex; P W Nelson; V L Paetznick; M Lozano-Chiu; A Espinel-Ingroff; E J Anaissie
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

5.  Susceptibility testing of fluconazole by the NCCLS broth macrodilution method, E-test, and disk diffusion for application in the routine laboratory.

Authors:  Inge Vandenbossche; Mario Vaneechoutte; Marleen Vandevenne; Thierry De Baere; Gerda Verschraegen
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

6.  Comparative evaluation of National Committee for Clinical Laboratory Standards broth macrodilution and agar dilution screening methods for testing fluconazole susceptibility of Cryptococcus neoformans.

Authors:  W R Kirkpatrick; R K McAtee; S G Revankar; A W Fothergill; D I McCarthy; M G Rinaldi; T F Patterson
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

7.  Rapid antifungal susceptibility determination for yeast isolates by use of Etest performed directly on blood samples from patients with fungemia.

Authors:  Jesús Guinea; Sandra Recio; Pilar Escribano; Marta Torres-Narbona; Teresa Peláez; Carlos Sánchez-Carrillo; Marta Rodríguez-Créixems; Emilio Bouza
Journal:  J Clin Microbiol       Date:  2010-04-14       Impact factor: 5.948

8.  Comparison of visual and spectrophotometric methods of broth microdilution MIC end point determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailing Candida isolates.

Authors:  Beth A Arthington-Skaggs; Wendy Lee-Yang; Meral A Ciblak; Joao P Frade; Mary E Brandt; Rana A Hajjeh; Lee H Harrison; Andre N Sofair; David W Warnock
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

9.  Interlaboratory evaluation of Etest method for testing antifungal susceptibilities of pathogenic yeasts to five antifungal agents by using Casitone agar and solidified RPMI 1640 medium with 2% glucose.

Authors:  A Espinel-Ingroff; M Pfaller; M E Erwin; R N Jones
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

10.  Comparison of two alternative microdilution procedures with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro testing of fluconazole-resistant and -susceptible isolates of Candida albicans.

Authors:  A Espinel-Ingroff; J L Rodríguez-Tudela; J V Martínez-Suárez
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.